This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Emory University, Sloan-Kettering Institute for Cancer Research. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Decatur, GA (US) (2014)
- Atlanta, GA (US) (2018)
Company Filing History:


Years Active: 2014-2018
Title: Alyson Irene Swimm: Innovator in Medical Treatments
Introduction
Alyson Irene Swimm is a notable inventor based in Decatur, GA (US). She has made significant contributions to the field of medical treatments, particularly in the management of graft versus host disease and pathogenic infections. With a total of 2 patents, her work has the potential to impact many lives.
Latest Patents
Alyson's latest patents include innovative methods for managing graft versus host disease (GvHD) using indole carboxyaldehydes or derivatives thereof. This patent outlines methods for treating or preventing GvHD by administering effective amounts of indole-2-carboxyaldehyde or indole-3-carboxyaldehyde to subjects in need. Additionally, she has developed compositions and methods for using tyrosine kinase inhibitors to treat pathogenic infections, particularly those caused by microbial pathogens such as bacteria and viruses.
Career Highlights
Throughout her career, Alyson has worked with prestigious institutions, including Emory University and the Sloan Kettering Institute for Cancer Research. Her research has focused on developing effective treatments for serious medical conditions, showcasing her dedication to advancing healthcare.
Collaborations
Alyson has collaborated with esteemed colleagues, including Daniel Kalman and William G. Bornmann. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Alyson Irene Swimm is a pioneering inventor whose work in medical treatments is making a significant difference in the field. Her patents reflect her commitment to improving patient outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile